# Study of Mirtazapine for Agitation in Dementia

> **NCT03031184** · PHASE3 · COMPLETED · sponsor: **University of Sussex** · enrollment: 207 (actual)

## Conditions studied

- Dementia

## Interventions

- **DRUG:** Mirtazapine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03031184
- **Lead sponsor:** University of Sussex
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2020-06
- **Final completion:** 2021-03
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2021-04-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03031184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03031184, "Study of Mirtazapine for Agitation in Dementia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03031184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*